San Diego, USA—February 11, 2025 — Crown Bioscience, a global contract research organization (CRO) headquartered in the United States and a part of JSR Life Sciences and Japan-based JSR Corporation, today announced that its Hamburg site in Germany has been awarded continued accreditation to the globally recognized ISO 15189:2022 standard by the College of American Pathologists (CAP). This distinction underscores the company’s unwavering dedication to quality and demonstrates technical excellence in laboratory services.
The ISO 15189 standard provides laboratories with a rigorous framework for quality management, risk assessment, and continuous improvement. Accreditation is based on stringent requirements specific to medical laboratories. Crown Bioscience's commitment to these standards affirms its focus on reducing risk and enhancing patient safety.
"We are extremely proud to have our ISO 15189 accreditation continued by CAP," said Simone Hubo, PhD, Director of Quality and Regulatory Affairs at Crown Bioscience Germany. "Our clients can feel confident trusting our teams to deliver reliable, technically competent services."
Crown Bioscience, operating across 11 sites globally, provides pharmaceutical and biotech clients with industry-leading preclinical and translational drug research and development platforms and services. Its Hamburg site offers a comprehensive biobank of liquid and tissue specimens complete with clinical histories, bioanalytical and biomarker testing capabilities, and other advanced laboratory services.
The continued CAP ISO 15189 further builds on the company’s reputation established by its previous CAP accreditation for biospecimen and tissue management practices awarded in June 2023. These accomplishments reinforce Crown Bioscience’s position as a leading provider of innovative oncology solutions, and its commitment to the highest standards and generating reliable results that clients need to advance innovative new oncology therapies.
Media Inquiries:
Crown Bioscience
Sarah Martin-Tyrrell
pr@crownbio.com
